Skip to content
  • Sunday, 23 August 2026
  • 3:51 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Traumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential

Lana Keisha Jun 26, 2026 0

Traumatic brain injury (TBI) stands as a formidable global health challenge, impacting an estimated 69 million individuals annually across all…

Read More
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential

Lana Keisha Jun 17, 2026 0

Traumatic brain injury (TBI) represents a formidable global public health challenge, impacting an estimated 69 million individuals each year across…

Read More
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential

Lana Keisha May 30, 2026 0

Traumatic brain injury (TBI) stands as a profound and pervasive global health crisis, impacting an estimated 69 million individuals each…

Read More
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential

Lana Keisha May 23, 2026 0

Traumatic Brain Injury (TBI) stands as a formidable global public health crisis, impacting an estimated 69 million individuals annually across…

Read More
Brain Tumors Induce Widespread disruption of Calvarial Bone and Alteration of Skull Marrow Immune LandscapeIndiana University School of Medicine Researchers Pioneer Advanced Multiplex Imaging Technique to Unlock the Mysteries of Bone MarrowAccelerated Pathways: A Strategic Approach to Fast-Track Qualifications in Today’s Dynamic Career LandscapeThe Paradoxical Protein: Sea Anemones Reveal a Novel Antiviral Defense Strategy, Challenging Evolutionary Assumptions
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ